Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism

Venous thromboembolism (VTE) whether provoked or not can be life-threatening due to an acute increase in load on the right ventricle (RV) from obstruction of the pulmonary artery (PA). Treatment for and prevention of VTE involves anti-thrombotic agents; more specifically, medications targeting the a...

Full description

Bibliographic Details
Main Authors: Joseph Van Galen, Libia Pava, Colin Wright, Ayman Elbadawi, Annelise Hamer, Abhishek Chaturvedi, Scott J. Cameron
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Platelets
Subjects:
Online Access:http://dx.doi.org/10.1080/09537104.2020.1732329
_version_ 1797684178886590464
author Joseph Van Galen
Libia Pava
Colin Wright
Ayman Elbadawi
Annelise Hamer
Abhishek Chaturvedi
Scott J. Cameron
author_facet Joseph Van Galen
Libia Pava
Colin Wright
Ayman Elbadawi
Annelise Hamer
Abhishek Chaturvedi
Scott J. Cameron
author_sort Joseph Van Galen
collection DOAJ
description Venous thromboembolism (VTE) whether provoked or not can be life-threatening due to an acute increase in load on the right ventricle (RV) from obstruction of the pulmonary artery (PA). Treatment for and prevention of VTE involves anti-thrombotic agents; more specifically, medications targeting the anticoagulation cascade. In spite of the widespread acceptance of anticoagulants in the treatment of VTE, there appears to be an ongoing belief that platelet reactivity contributes to thrombus burden in patients with acute pulmonary embolism (PE). This investigation of 398 patients presenting with acute PE evaluated whether anti-platelet medication use, which consisted mostly of aspirin therapy, at the time of presentation, affects PA thrombus burden, RV load, or short-term patient outcomes. We conclude that platelets may have been erroneously incriminated as direct thrombotic mediators in patients with acute PE since aspirin neither decreased PA thrombus burden, nor did aspirin improve short-term mortality following acute PE.
first_indexed 2024-03-12T00:25:49Z
format Article
id doaj.art-089d858af4c643f38d7f3ddc89b7eb1d
institution Directory Open Access Journal
issn 0953-7104
1369-1635
language English
last_indexed 2024-03-12T00:25:49Z
publishDate 2021-01-01
publisher Taylor & Francis Group
record_format Article
series Platelets
spelling doaj.art-089d858af4c643f38d7f3ddc89b7eb1d2023-09-15T10:38:07ZengTaylor & Francis GroupPlatelets0953-71041369-16352021-01-0132113814010.1080/09537104.2020.17323291732329Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolismJoseph Van Galen0Libia Pava1Colin Wright2Ayman Elbadawi3Annelise Hamer4Abhishek Chaturvedi5Scott J. Cameron6University of VirginiaUniversity of Rochester School of MedicineUniversity of Rochester School of MedicineUniversity of Texas Medical BranchUniversity of Rochester School of MedicineUniversity of Rochester School of MedicineUniversity of Rochester School of MedicineVenous thromboembolism (VTE) whether provoked or not can be life-threatening due to an acute increase in load on the right ventricle (RV) from obstruction of the pulmonary artery (PA). Treatment for and prevention of VTE involves anti-thrombotic agents; more specifically, medications targeting the anticoagulation cascade. In spite of the widespread acceptance of anticoagulants in the treatment of VTE, there appears to be an ongoing belief that platelet reactivity contributes to thrombus burden in patients with acute pulmonary embolism (PE). This investigation of 398 patients presenting with acute PE evaluated whether anti-platelet medication use, which consisted mostly of aspirin therapy, at the time of presentation, affects PA thrombus burden, RV load, or short-term patient outcomes. We conclude that platelets may have been erroneously incriminated as direct thrombotic mediators in patients with acute PE since aspirin neither decreased PA thrombus burden, nor did aspirin improve short-term mortality following acute PE.http://dx.doi.org/10.1080/09537104.2020.1732329aspirinplateletpulmonary embolismthrombus
spellingShingle Joseph Van Galen
Libia Pava
Colin Wright
Ayman Elbadawi
Annelise Hamer
Abhishek Chaturvedi
Scott J. Cameron
Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism
Platelets
aspirin
platelet
pulmonary embolism
thrombus
title Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism
title_full Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism
title_fullStr Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism
title_full_unstemmed Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism
title_short Effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism
title_sort effect of platelet inhibitors on thrombus burden in patients with acute pulmonary embolism
topic aspirin
platelet
pulmonary embolism
thrombus
url http://dx.doi.org/10.1080/09537104.2020.1732329
work_keys_str_mv AT josephvangalen effectofplateletinhibitorsonthrombusburdeninpatientswithacutepulmonaryembolism
AT libiapava effectofplateletinhibitorsonthrombusburdeninpatientswithacutepulmonaryembolism
AT colinwright effectofplateletinhibitorsonthrombusburdeninpatientswithacutepulmonaryembolism
AT aymanelbadawi effectofplateletinhibitorsonthrombusburdeninpatientswithacutepulmonaryembolism
AT annelisehamer effectofplateletinhibitorsonthrombusburdeninpatientswithacutepulmonaryembolism
AT abhishekchaturvedi effectofplateletinhibitorsonthrombusburdeninpatientswithacutepulmonaryembolism
AT scottjcameron effectofplateletinhibitorsonthrombusburdeninpatientswithacutepulmonaryembolism